Brain wave patterns and inflammation: a clue to ECT's effectiveness in older adults?

NCT ID NCT07740694

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study investigates whether brain wave patterns (measured by EEG) and inflammatory markers in the blood can help predict how well older adults with depression or bipolar disorder respond to electroconvulsive therapy (ECT). Researchers will compare EEG recordings and blood samples taken before and after ECT treatment, looking for changes that correlate with clinical improvement. The goal is to better understand how ECT works in the aging brain and potentially identify biomarkers that could guide personalized treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Electroconvulsive therapy (ECT) using the Thymatron System IV device
What this could lead to
If successful, this could help predict which older adults with depression or bipolar disorder will benefit most from ECT, and may guide more personalized treatment decisions.
What could go wrong
This is an observational study, so it won't directly test a new treatment. The findings may not apply to all patients, and the relationship between biomarkers and ECT response could be complex and not definitive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR AFFECTIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • İstanbul University- Cerrahpasa, Cerrahpasa Medicine Faculty, Psychiatry Department

    RECRUITING

    Istanbul, Bakırköy, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.